Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study
Lucas Armange
,
François Bénézit
(1)
,
Léa Picard
(1)
,
Charlotte Pronier
(1)
,
Stéphanie Guillot
(1)
,
Pierre-Axel Lentz
(1)
,
François Carré
(1)
,
Pierre Tattevin
(1, 2)
,
Matthieu Revest
(1, 2)
Lucas Armange
- Fonction : Auteur
François Carré
- Fonction : Auteur
- PersonId : 947746
Pierre Tattevin
Connectez-vous pour contacter l'auteur
- Fonction : Auteur correspondant
- PersonId : 945604
Connectez-vous pour contacter l'auteur
Matthieu Revest
- Fonction : Auteur
- PersonId : 765595
- ORCID : 0000-0001-8896-3060
- IdRef : 120446855
Résumé
We performed a prospective cohort study of 311 outpatients with non-severe COVID-19 (187 women, median age 39 years). Of the 214 (68.8%) who completed the 6-week follow-up questionnaire, 115 (53.7%) had recovered. Others mostly reported dyspnea (n = 86, 40.2%), weight loss (n = 83, 38.8%), sleep disorders (n = 68, 31.8%), and anxiety (n = 56, 26.2%). Of those who developed ageusia and anosmia, these symptoms were still present at week 6 in, respectively, 11/111 (9.9%) and 19/114 (16.7%). Chest CT scan and lung function tests found no explanation in the most disabled patients (n = 23). This study confirms the high prevalence of persistent symptoms after non-severe COVID-19.
Domaines
Sciences du Vivant [q-bio]Format du dépôt | Notice |
---|---|
Type de dépôt | Article dans une revue |
Titre |
en
Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study
|
Résumé |
en
We performed a prospective cohort study of 311 outpatients with non-severe COVID-19 (187 women, median age 39 years). Of the 214 (68.8%) who completed the 6-week follow-up questionnaire, 115 (53.7%) had recovered. Others mostly reported dyspnea (n = 86, 40.2%), weight loss (n = 83, 38.8%), sleep disorders (n = 68, 31.8%), and anxiety (n = 56, 26.2%). Of those who developed ageusia and anosmia, these symptoms were still present at week 6 in, respectively, 11/111 (9.9%) and 19/114 (16.7%). Chest CT scan and lung function tests found no explanation in the most disabled patients (n = 23). This study confirms the high prevalence of persistent symptoms after non-severe COVID-19.
|
Auteur(s) |
Lucas Armange
, François Bénézit
1
, Léa Picard
1
, Charlotte Pronier
1
, Stéphanie Guillot
1
, Pierre-Axel Lentz
1
, François Carré
1
, Pierre Tattevin
1, 2
, Matthieu Revest
1, 2
1
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
( 301327 )
- 2 Rue Henri le Guilloux, 35000 Rennes
- France
2
BRM -
ARN régulateurs bactériens et médecine
( 480855 )
- Faculté de Pharmacie - Campus Santé Villejean - 2, avenue Prof. Léon Bernard - Bâtiment 5 - 2e étage - CS 34317 - 35043 Rennes cedex
- France
|
Date de publication électronique |
2021-04-25
|
Langue du document |
Anglais
|
Vulgarisation |
Non
|
Comité de lecture |
Oui
|
Audience |
Internationale
|
Nom de la revue |
|
Date de publication |
2021-04-23
|
Page/Identifiant |
2421-2425
|
Volume |
40
|
Numéro |
11
|
Domaine(s) |
|
Mots-clés |
en
Asthenia, COVID-19, Dyspnea, Investigations, Persistent symptoms, Prospective cohort
|
DOI | 10.1007/s10096-021-04261-y |
Pubmed Id | 33893570 |
PubMed Central | PMC8064701 |
Loading...